Apogee Therapeutics (APGE)

• Market cap: $4.95B
• 1 day: 3.37%
• 5 days: -11.12%
• 1 month: -5.24%
• 3 months: 28.72%
• 6 months: 82.5%
• Year to date: -4.49%
• 1 year: 79.96%
• 5 years: 240.93%
• 10 years: 240.93%
• Sector: Healthcare
• Industry: Biotechnology

About: Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Employees: 196